Key points: Most cases of ibrutinib-resistant CLL were due to mutations in BTK and/or PLCG2 and often composed of multiple independent subclones. High sensitivity testing identified resistance mutations up to 15 months before manifestation of clinical progression.
Home / Resource Library / Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia